Advertisement

More articles from Research Articles

  • Characterization of the Genomic and Immunologic Diversity of Malignant Brain Tumors through Multisector Analysis
    Maximilian O. Schaettler, Megan M. Richters, Anthony Z. Wang, Zachary L. Skidmore, Bryan Fisk, Katherine E. Miller, Tammi L. Vickery, Albert H. Kim, Michael R. Chicoine, Joshua W. Osbun, Eric C. Leuthardt, Joshua L. Dowling, Gregory J. Zipfel, Ralph G. Dacey, Hsiang-Chih Lu, Tanner M. Johanns, Obi L. Griffith, Elaine R. Mardis, Malachi Griffith, Gavin P. Dunn
    Cancer Discovery Jan 2022, 12 (1) 154-171; DOI: 10.1158/2159-8290.CD-21-0291
  • RTK-Dependent Inducible Degradation of Mutant PI3Kα Drives GDC-0077 (Inavolisib) Efficacy
    Kyung W. Song, Kyle A. Edgar, Emily J. Hanan, Marc Hafner, Jason Oeh, Mark Merchant, Deepak Sampath, Michelle A. Nannini, Rebecca Hong, Lilian Phu, William F. Forrest, Eric Stawiski, Stephen Schmidt, Nicholas Endres, Jane Guan, Jeffrey J. Wallin, Jonathan Cheong, Emile G. Plise, Gail D. Lewis Phillips, Laurent Salphati, Timothy P. Heffron, Alan G. Olivero, Shiva Malek, Steven T. Staben, Donald S. Kirkpatrick, Anwesha Dey, Lori S. Friedman
    Cancer Discovery Jan 2022, 12 (1) 204-219; DOI: 10.1158/2159-8290.CD-21-0072
  • Mitochondrial Fragmentation Triggers Ineffective Hematopoiesis in Myelodysplastic Syndromes
    Yasushige Aoyagi, Yoshihiro Hayashi, Yuka Harada, Kwangmin Choi, Natsumi Matsunuma, Daichi Sadato, Yuki Maemoto, Akihiro Ito, Shigeru Yanagi, Daniel T. Starczynowski, Hironori Harada
    Cancer Discovery Jan 2022, 12 (1) 250-269; DOI: 10.1158/2159-8290.CD-21-0032
  • Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy
    Fernanda G. Herrera, Catherine Ronet, Maria Ochoa de Olza, David Barras, Isaac Crespo, Massimo Andreatta, Jesus Corria-Osorio, Aodrenn Spill, Fabrizio Benedetti, Raphael Genolet, Angela Orcurto, Martina Imbimbo, Eleonora Ghisoni, Blanca Navarro Rodrigo, Dominik R. Berthold, Apostolos Sarivalasis, Khalil Zaman, Rafael Duran, Clarisse Dromain, John Prior, Niklaus Schaefer, Jean Bourhis, Georgia Dimopoulou, Zoi Tsourti, Marius Messemaker, Thomas Smith, Sarah E. Warren, Periklis Foukas, Sylvie Rusakiewicz, Mikaël J. Pittet, Stefan Zimmermann, Christine Sempoux, Urania Dafni, Alexandre Harari, Lana E. Kandalaft, Santiago J. Carmona, Denarda Dangaj Laniti, Melita Irving, George Coukos
    Cancer Discovery Jan 2022, 12 (1) 108-133; DOI: 10.1158/2159-8290.CD-21-0003
  • Prolonged SARS-CoV-2 Infection in Patients with Lymphoid Malignancies
    Christina Y. Lee, Monika K. Shah, David Hoyos, Alexander Solovyov, Melanie Douglas, Ying Taur, Peter Maslak, N. Esther Babady, Benjamin Greenbaum, Mini Kamboj, Santosha A. Vardhana
    Cancer Discovery Jan 2022, 12 (1) 62-73; DOI: 10.1158/2159-8290.CD-21-1033
  • Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor–Resistant, EGFR-Mutated Non–Small Cell Lung Cancer
    Pasi A. Jänne, Christina Baik, Wu-Chou Su, Melissa L. Johnson, Hidetoshi Hayashi, Makoto Nishio, Dong-Wan Kim, Marianna Koczywas, Kathryn A. Gold, Conor E. Steuer, Haruyasu Murakami, James Chih-Hsin Yang, Sang-We Kim, Michele Vigliotti, Rong Shi, Zhenhao Qi, Yang Qiu, Lihui Zhao, David Sternberg, Channing Yu, Helena A. Yu
    Cancer Discovery Jan 2022, 12 (1) 74-89; DOI: 10.1158/2159-8290.CD-21-0715
  • Rates and Patterns of Clonal Oncogenic Mutations in the Normal Human Brain
    Javier Ganz, Eduardo A. Maury, Basheer Becerra, Sara Bizzotto, Ryan N. Doan, Connor J. Kenny, Taehwan Shin, Junho Kim, Zinan Zhou, Keith L. Ligon, Eunjung Alice Lee, Christopher A. Walsh
    Cancer Discovery Jan 2022, 12 (1) 172-185; DOI: 10.1158/2159-8290.CD-21-0245
  • PRC2 Inhibitors Overcome Glucocorticoid Resistance Driven by NSD2 Mutation in Pediatric Acute Lymphoblastic Leukemia
    Jianping Li, Julia Hlavka-Zhang, Jonathan H. Shrimp, Crissandra Piper, Daphne Dupéré-Richér, Jacob S. Roth, Duohui Jing, Heidi L. Casellas Román, Catalina Troche, Alok Swaroop, Marta Kulis, Jon A. Oyer, Christine M. Will, Min Shen, Alberto Riva, Richard L. Bennett, Adolfo A. Ferrando, Matthew D. Hall, Richard B. Lock, Jonathan D. Licht
    Cancer Discovery Jan 2022, 12 (1) 186-203; DOI: 10.1158/2159-8290.CD-20-1771
  • Spatiotemporal Immune Landscape of Colorectal Cancer Liver Metastasis at Single-Cell Level
    Yingcheng Wu, Shuaixi Yang, Jiaqiang Ma, Zechuan Chen, Guohe Song, Dongning Rao, Yifei Cheng, Siyuan Huang, Yifei Liu, Shan Jiang, Jinxia Liu, Xiaowu Huang, Xiaoying Wang, Shuangjian Qiu, Jianmin Xu, Ruibin Xi, Fan Bai, Jian Zhou, Jia Fan, Xiaoming Zhang, Qiang Gao
    Cancer Discovery Jan 2022, 12 (1) 134-153; DOI: 10.1158/2159-8290.CD-21-0316
  • Systematic Profiling of DNMT3A Variants Reveals Protein Instability Mediated by the DCAF8 E3 Ubiquitin Ligase Adaptor
    Yung-Hsin Huang, Chun-Wei Chen, Venkatasubramaniam Sundaramurthy, Mikołaj Słabicki, Dapeng Hao, Caroline J. Watson, Ayala Tovy, Jaime M. Reyes, Olga Dakhova, Brielle R. Crovetti, Christina Galonska, Minjung Lee, Lorenzo Brunetti, Yubin Zhou, Katrina Tatton-Brown, Yun Huang, Xiaodong Cheng, Alexander Meissner, Peter J.M. Valk, Lionel Van Maldergem, Mathijs A. Sanders, Jamie R. Blundell, Wei Li, Benjamin L. Ebert, Margaret A. Goodell
    Cancer Discovery Jan 2022, 12 (1) 220-235; DOI: 10.1158/2159-8290.CD-21-0560

Pages